By Iain Gilbert
Date: Thursday 15 Aug 2024
(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.
Gilham, who took over as chairman in May 2015, purchased the shares on Wednesday at an average price of 3.10p, for a total price of £31,000.
As of 1615...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news